Literature DB >> 16236091

Improving glucose management: ten steps to get more patients with type 2 diabetes to glycaemic goal.

S Del Prato1, A-M Felton, N Munro, R Nesto, P Zimmet, B Zinman.   

Abstract

Despite increasingly stringent clinical practice guidelines for glycaemic control, the implementation of recommendations has been disappointing, with over 60% of patients not reaching recommended glycaemic goals. As a result, current management of glycaemia falls significantly short of accepted treatment goals. The Global Partnership for Effective Diabetes Management has identified a number of major barriers that can prevent individuals from achieving their glycaemic targets. This article proposes 10 key practical recommendations to aid healthcare providers in overcoming these barriers and to enable a greater proportion of patients to achieve glycaemic goals. These include advice on targeting the underlying pathophysiology of type 2 diabetes, treating early and effectively with combination therapies, adopting a holistic, multidisciplinary approach and improving patient understanding of type 2 diabetes. Implementation of these recommendations should reduce the risk of diabetes-related complications, improve patient quality of life and impact more effectively on the increasing healthcare cost related to diabetes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16236091     DOI: 10.1111/j.1742-1241.2005.00674.x

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  41 in total

Review 1.  Glycemic control and weight reduction without causing hypoglycemia: the case for continued safe aggressive care of patients with type 2 diabetes mellitus and avoidance of therapeutic inertia.

Authors:  Stanley S Schwartz; Benjamin A Kohl
Journal:  Mayo Clin Proc       Date:  2010-11-24       Impact factor: 7.616

2.  Physicians' perceptions of the type 2 diabetes multi-disciplinary treatment team: a qualitative study.

Authors:  Marilyn D Ritholz; Elizabeth A Beverly; Martin J Abrahamson; Kelly M Brooks; Brittney A Hultgren; Katie Weinger
Journal:  Diabetes Educ       Date:  2011-10-14       Impact factor: 2.140

Review 3.  Early Combination Therapy with Oral Glucose-Lowering Agents in Type 2 Diabetes.

Authors:  Cristina Bianchi; Giuseppe Daniele; Angela Dardano; Roberto Miccoli; Stefano Del Prato
Journal:  Drugs       Date:  2017-03       Impact factor: 9.546

4.  New therapeutic algorithm of Type 2 diabetes: lights and shadows.

Authors:  A Consoli
Journal:  J Endocrinol Invest       Date:  2011-02-04       Impact factor: 4.256

Review 5.  From glucose lowering agents to disease/diabetes modifying drugs: a "SIMPLE" approach for the treatment of type 2 diabetes.

Authors:  Ofri Mosenzon; Stefano Del Prato; Meir Schechter; Lawrence A Leiter; Antonio Ceriello; Ralph A DeFronzo; Itamar Raz
Journal:  Cardiovasc Diabetol       Date:  2021-04-28       Impact factor: 9.951

6.  Impact of Disease Management Programs on HbA1c Values in Type 2 Diabetes Patients in Germany.

Authors:  Karel Kostev; Timo Rockel; Louis Jacob
Journal:  J Diabetes Sci Technol       Date:  2016-07-10

Review 7.  Insulin analogs or premixed insulin analogs in combination with oral agents for treatment of type 2 diabetes.

Authors:  Philip Levy
Journal:  MedGenMed       Date:  2007-04-16

Review 8.  Tailoring treatment to the individual in type 2 diabetes practical guidance from the Global Partnership for Effective Diabetes Management.

Authors:  S Del Prato; J LaSalle; S Matthaei; C J Bailey
Journal:  Int J Clin Pract       Date:  2010-02       Impact factor: 2.503

Review 9.  Practical steps to improving the management of type 1 diabetes: recommendations from the Global Partnership for Effective Diabetes Management.

Authors:  P Aschner; E Horton; L A Leiter; N Munro; J S Skyler
Journal:  Int J Clin Pract       Date:  2010-02       Impact factor: 2.503

Review 10.  Changing the treatment paradigm for type 2 diabetes.

Authors:  Stefano Del Prato; Giuseppe Penno; Roberto Miccoli
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.